Clinical Trial Update: Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 [Phase 3]

View source ↗

Summary

Clinical trial update indicating completion of a Phase 3 study of Sofosbuvir, Ledipasvir, and Ribavirin for genotype 1 hepatitis C in patients with cirrhosis. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis C

Drugs mentioned

• Ledipasvir (ledipasvir)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Hepatitis C, Cirrhosis | Phase 3 | Status: COMPLETED